Healthcare [ 13/13 ] | Medical Devices [ 113/164 ]
NASDAQ | Common Stock
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide.
The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments.
The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.
The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices.
The Advanced Circulatory Support segment develops, produces, and sells temporary life support products.
It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers.
The company sells its products through direct sales representatives and independent distributors.
LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 1, 24 | 0.73 Increased by +69.77% | 0.49 Increased by +48.98% |
| Feb 21, 24 | 0.87 Increased by +7.41% | 0.77 Increased by +12.99% |
| Nov 1, 23 | 0.73 Increased by +25.86% | 0.64 Increased by +14.06% |
| Jul 26, 23 | 0.78 Increased by +47.17% | 0.54 Increased by +44.44% |
| May 3, 23 | 0.43 Decreased by -10.42% | 0.39 Increased by +10.26% |
| Feb 22, 23 | 0.81 Increased by +42.11% | 0.73 Increased by +10.96% |
| Nov 2, 22 | 0.58 Decreased by -14.71% | 0.55 Increased by +5.45% |
| Aug 3, 22 | 0.53 Increased by +1.92% | 0.52 Increased by +1.92% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 24 | 294.90 M Increased by +11.96% | -41.90 M Decreased by -668.52% | Decreased by -14.21% Decreased by -607.79% |
| Dec 31, 23 | 310.10 M Increased by +12.80% | 16.34 M Increased by +883.68% | Increased by +5.27% Increased by +772.02% |
| Sep 30, 23 | 286.10 M Increased by +13.26% | -7.30 M Increased by +93.20% | Decreased by -2.55% Increased by +94.00% |
| Jun 30, 23 | 293.90 M Increased by +15.62% | 1.16 M Decreased by -92.98% | Increased by +0.39% Decreased by -93.92% |
| Mar 31, 23 | 263.40 M Increased by +9.67% | 7.37 M Increased by +146.24% | Increased by +2.80% Increased by +124.53% |
| Dec 31, 22 | 274.90 M Increased by +1.78% | 1.66 M Increased by +132.57% | Increased by +0.60% Increased by +132.00% |
| Sep 30, 22 | 252.60 M Decreased by -0.24% | -107.40 M Decreased by -154.28% | Decreased by -42.52% Decreased by -154.90% |
| Jun 30, 22 | 254.20 M Decreased by -3.89% | 16.44 M Increased by +129.73% | Increased by +6.47% Increased by +130.93% |